Detection of occult hepatitis B virus infection among blood donors in Sudan

Journal of the Egyptian Public Health Association

Volumn 88, Issue 1, 2013, Pages 14-18

  El Kader Mahmoud, Ola Abd ^a   El Rahim Ghazal, Abeer Abd ^a   El Sayed Metwally, Dalia ^a   Elnour, Ahmed Mohamed ^b   Yousif, Ghanim Eltahir Ahmed ^c  

^a ALEXANDRIA UNIVERSITY   (Egypt)

^b University of El Imam El Mahdi   (Sudan)

^c UNIVERSITY OF KHARTOUM   (Sudan)

Author keywords

And X genes; Blood donors; C; Occult hepatitis B virus; S

Indexed keywords

VIRUS DNA;

BLOOD; BLOOD DONOR; CROSS-SECTIONAL STUDY; GENETICS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER TUMOR; SUDAN;

BLOOD DONORS; CROSS-SECTIONAL STUDIES; DNA, VIRAL; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LIVER NEOPLASMS; SUDAN;

EID: 84876268225     PISSN: 00132446     EISSN: 2090262X     Source Type: Journal    
DOI: 10.1097/01.EPX.0000427065.73965.c8     Document Type: Article

References (37)

1. World Health Organization Hepatitis B. World Health Organization Fact Sheet No. 204. 2012. Available at: http://www.who.int/mediacentre/factsheets/ fs204/en/.
2. Lok AS. Chronic hepatitis B. N Engl J Med 2002; 346:1682-1683.
3. Liu Y, Li P, Li C, Zhou J,Wu C, Zhou Y-H. Detection of hepatitis B virus DNA among accepted blood donors in Nanjing, China. Virol J 2010; 7:193. doi: 10.1186/1743-422X-7-193.
4. Raimondo G/, Allain J-P, Brunetto MR, Buendia M-A, Chen D-S, Colombo M, et al. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol 2008; 49:652-657.
5. Mudawi HM. Epidemiology of viral hepatitis in Sudan. Clin Exp Gastroenterol 2008; 1:9-13.
6. Norder H, Hammas B, Larsen J, Skaug K, Magnius LO. Detection of HBV DNA by PCR in serum from an HBsAg negative blood donor implicated in cases of post-transfusion hepatitis B. Arch Virol Suppl 1992; 4:116-118.
7. Said ZNA. An overview of occult hepatitis B virus infection. World J Gastroenterol 2011; 17:1927-1938.
8. Hollinger FB. Hepatitis B virus infection and transfusion medicine: science and the occult. Transfusion 2008; 48:1001-1026.
9. Hollinger FB, Sood G. Occult hepatitis B virus infection: a covert operation. J Viral Hepat 2010; 17:1-15.
10. Wood B. Essentials of medical statistics. London: Blackwell Scientific Publications Ch 26; 1988. pp. 191-194.
11. Kao J-H, Chen P-J, Lai M-Y, Chen D-S. Occult hepatitis B virus infection and clinical outcomes of patients with chronic hepatitis C. J Clin Microbiol 2002; 40:4068-4071.
12. Raimondo G, Pollicino T, Cacciola I, Squadrito G. Occult hepatitis B virus infection. J Hepatol 2007; 46:160-170.
13. Chazouillères O, Mamish D, Kim M, Carey K, Ferrell L, Roberts JP, et al. 'Occult' hepatitis B virus as source of infection in liver transplant recipients. Lancet 1994; 343:142-146.
14. Grob P, Jilg W, Bornhak H, Gerken G, Gerlich W, Günther S, et al. Serological pattern'anti-HBc alone': report on a workshop. J Med Virol 2000; 62:450-455.
15. De Almeida Neto C, Strauss E, Sabino EC, Sucupira MCA, Chamone DDAF. Significance of isolated hepatitis B core antibody in blood donors from São Paulo. Rev Inst Med Trop Sao Paulo 2001; 43:203-208.
16. Rehermann B, Ferrari C, Pasquinelli C, Chisari FV. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med 1996; 2:1104-1108.
17. Hassan ZK, Hafez MM, Mansor TM, Zekri ARN. Occult HBV infection among Egyptian hepatocellular carcinoma patients. Virol J 2011; 8:90. doi: 10.1186/1743-422X-8-90.
18. Ramia S, Sharara AI, El-Zaatari M, Ramlawi F, Mahfoud Z. Occult hepatitis B virus infection in Lebanese patients with chronic hepatitis C liver disease. Eur J Clin Microbiol Infect Dis 2008; 27:217-221.
19. Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando ME, Raimondo G. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med 1999; 341:22-26.
20. Ocana S, Casas ML, Buhigas I, Lledo JL. Diagnostic strategy for occult hepatitis B virus infection. World J Gastroenterol 2011; 17: 1553-1557.
21. Squadrito G, Orlando ME, Pollicino T, Raffa G, Restuccia T, Cacciola I, et al. Virological profiles in patients with chronic hepatitis C and overt or occult HBV infection. Am J Gastroenterol 2002; 97:1518-1523.
22. Allice T, Cerutti F, Pittaluga F, Varetto S, Gabella S, Marzano A, et al. COBAS AmpliPrep-COBAS TaqMan hepatitis B virus (HBV) test: a novel automated real-time PCR assay for quantification of HBV DNA in plasma. J Clin Microbiol 2007; 45:828-834.
23. Levast M, Larrat S, Thelu M-A, Nicod S, Plages A, Cheveau A, et al. Prevalence and impact of occult hepatitis B infection in chronic hepatitis C patients treated with pegylated interferon and ribavirin. J Med Virol 2010; 82:747-754.
24. Sagnelli E, Imparato M, Coppola N, Pisapia R, Sagnelli C, Messina V, et al. Diagnosis and clinical impact of occult hepatitis B infection in patients with biopsy proven chronic hepatitis C: a multicenter study. J Med Virol 2008; 80:1547-1553.
25. Shetty K, Hussain M, Nei L, Reddy KR, Lok ASF. Prevalence and significance of occult hepatitis B in a liver transplant population with chronic hepatitis C. Liver Transpl 2008; 14:534-540.
26. Kleinman SH, Kuhns MC, Todd DS, Glynn SA, McNamara A, DiMarco A, Busch MP. Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening. Transfusion 2003; 43:696-704.
27. Kleinman SH, Strong DM, Tegtmeier GGE, Holland PV, Gorlin JB, Cousins CR, et al. Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test. Transfusion 2005; 45:1247-1257.
28. Linauts S, Saldanha J, Strong DM. PRISM hepatitis B surface antigen detection of hepatits B virus minipool nucleic acid testing yield samples. Transfusion 2008; 48:1376-1382.
29. Chevrier M-C, St-Louis M, Perreault J, Caron B, Castilloux C, Laroche J, Delage G. Detection and characterization of hepatitis B virus of anti-hepatitis B core antigen-reactive blood donors in Quebec with an in-house nucleic acid testing assay. Transfusion 2007; 47:1794-1802.
30. O'Brien SF, Fearon MA, Yi Q-L, Fan W, Scalia V, Muntz IR, Vamvakas E. Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience. Transfusion 2007; 47:1809-1815.
31. Hourfar MK, Jork C, Schottstedt V, Weber-Schehl M, Brixner V, Busch MP, et al. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus. Transfusion 2008; 48:1558-1566.
32. Bhatti FA, Ullah Z, Salamat N, Ayub M, Ghani E. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice. Transfusion 2007; 47:74-79.
33. Nantachit N, Thaikruea L, Thongsawat S, Leetrakool N, Fongsatikul L, Sompan P, et al. Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand. Transfusion 2007; 47: 1803-1808.
34. Satake M, Taira R, Yugi H, Hino S, Kanemitsu K, Ikeda H, Tadokoro K. Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program. Transfusion 2007; 47:1197-1205.
35. Tamori A, Yamanishi Y, Kawashima S, Kanehisa M, Enomoto M, Tanaka H, et al. Alteration of gene expression in human hepatocellular carcinoma with integrated hepatitis B virus DNA. Clin Cancer Res 2005; 11:5821-5826.
36. Peng Z, Zhang Y, Gu W, Wang Z, Li D, Zhang F, et al. Integration of the hepatitis B virus X fragment in hepatocellular carcinoma and its effects on the expression of multiple molecules: a key to the cell cycle and apoptosis. Int J Oncol 2005; 26:467-473.
37. Kleinman SH, Busch MP. Hbv: amplified and back in the blood safety spotlight. Transfusion 2001; 41:1081-1085.